Investors should avoid CCL stock as very little has changed and Carnival hasn't fulfilled its promise since the pandemic began. More
Articles
4 Reasons Why Bears May Be Underestimating Hyliion Stock
Companies are looking to get "greener," and Hyliion's solutions have some meaningful advantages over competing products. As a result, some investors should consider buying HYLN stock. More
Vinco Ventures Doesn’t Look Any Better After This M&A Announcement
Vinco Ventures made a big acquisition causing BBIG stock to jump almost 20%. However, the rally was short-lived. Here’s why that’s the case. More
Don’t Buy Too Much Into the WHO Hype Surrounding Ocugen Stock
Admittedly, one last boost may still be on the table, if meme traders use subsequent WHO news as reason to send OCGN stock back to double-digit prices. But with its high chances of ultimately collapsing in price, it's a stock most investors should avoid. More
The Shorts Are Right on Camber Energy Stock, but It’s Not Worth Joining Them
Going short on Camber Energy is a situation where the potential profits aren't enough to counter the danger of a short squeeze. Going long is a wager on renewed market madness. A tough situation to assess, it's best to invest elsewhere. Skip on CEI stock. More
Novavax Stock Will Find Its Bottom, But Probably not Soon
Down nearly 40% over the past month, NVAX stock has been on a steep decline that appears to be accelerating. At its current price of $163.06 per share, Novavax's stock is now 50% below its all-time high of $331.68 reached in February of this year. With the current slide showing no signs of stopping, shareholders may want to cut their losses. More
Robinhood Markets Has a Peter Pan Problem
Beyond getting into proxy voting through Say Technologies, Robinhood has done little to justify HOOD stock priced at 17x revenue since its IPO. More
